Back to Agenda
FDA Panel
Session Chair(s)
John Weiner, JD
Associate Director for Policy, Office of Combination Products, OCPP, OC, FDA, United States
Medical Product Center, Office of Combination Products, and Oncology Center of Excellence leadership will discuss plans, priorities, and challenges for combination products, enhancing coordination and collaboration more broadly, and the future face of FDA as the Agency addresses increasingly complex, cross-cutting medical products.
Speaker(s)
Panelist
James Bertram, PhD, MS, RAC
Director, Office of Combination Products, OC, FDA, United States
Panelist
Melissa Burns, MS
Senior Program Manager, Office of Combination Products, OCPP, OC, FDA, United States
Panelist
Sheryl L. Lard Whiteford, PhD
Associate Director for Quality Assurance, OCD, CBER, FDA, United States
Panelist
Kristina Lauritsen, PhD
Combination Products Regulatory Policy Advisor, OEP, CDER, FDA, United States
Have an account?